Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4291672
Max Phase: Preclinical
Molecular Formula: C77H102Cl6N12O15S3
Molecular Weight: 1744.65
Molecule Type: Unknown
Associated Items:
ID: ALA4291672
Max Phase: Preclinical
Molecular Formula: C77H102Cl6N12O15S3
Molecular Weight: 1744.65
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN1Cc2c(Cl)cc(Cl)cc2[C@@H](c2cccc(S(=O)(=O)NCCOCCOCCNC(=O)N(C)CCCN(CCCN(C)C(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)C(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)c2)C1
Standard InChI: InChI=1S/C77H102Cl6N12O15S3/c1-90-48-66(63-42-57(78)45-72(81)69(63)51-90)54-11-6-14-60(39-54)111(99,100)87-20-30-108-36-33-105-27-17-84-75(96)93(4)23-9-25-95(77(98)86-19-29-107-35-38-110-32-22-89-113(103,104)62-16-8-13-56(41-62)68-50-92(3)53-71-65(68)44-59(80)47-74(71)83)26-10-24-94(5)76(97)85-18-28-106-34-37-109-31-21-88-112(101,102)61-15-7-12-55(40-61)67-49-91(2)52-70-64(67)43-58(79)46-73(70)82/h6-8,11-16,39-47,66-68,87-89H,9-10,17-38,48-53H2,1-5H3,(H,84,96)(H,85,97)(H,86,98)/t66-,67+,68-/m0/s1
Standard InChI Key: LRGBKSUNUYVGHC-DOFIMEDASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1744.65 | Molecular Weight (Monoisotopic): 1740.4881 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. (2016) Nhe3-binding compounds and methods for inhibiting phosphate transport, |
Source(1):